Satoe Yokoyama

Effect of vitamin<scp>D</scp>supplementation on pegylated interferon/ribavirin therapy for chronic hepatitis<scp>C</scp>genotype 1b: a randomized controlled trial

Satoe Yokoyama, Shoichi Takahashi, Y. Kawakami et al. · Journal of Viral Hepatitis · 2013 · 35 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Predictive value of the IFNL4 polymorphism on outcome of telaprevir, peginterferon, and ribavirin therapy for older patients with genotype 1b chronic hepatitis C

Hatsue Fujino, Michio Imamura, Yuko Nagaoki et al. · Journal of Gastroenterology · 2013 · 23 citations

Pharmacy, Genetics, Pharmacotherapy +17

Non‐invasive liver fibrosis score calculated by combination of virtual touch tissue quantification and serum liver functional tests in chronic hepatitis <scp>C</scp> patients

Shintaro Takaki, Yoshiiku Kawakami, Daisuke Miyaki et al. · Hepatology Research · 2013 · 20 citations

Medicine, Biomedical Engineering, Pathology +17

Safety and efficacy of dual therapy with daclatasvir and asunaprevir for older patients with chronic hepatitis C

Reona Morio, Michio Imamura, Yoshiiku Kawakami et al. · Journal of Gastroenterology · 2016 · 20 citations

Pharmacy, Geriatric Medicine, Pharmacotherapy +16

Interferon lambda 4 polymorphism affects on outcome of telaprevir, pegylated interferon and ribavirin combination therapy for chronic hepatitis <scp>C</scp>

Yuko Nagaoki, Michio Imamura, Yoshiiku Kawakami et al. · Hepatology Research · 2014 · 13 citations

Pharmacy, Genetics, Pharmacotherapy +17